| アブストラクト | BACKGROUND: Some autoimmune diseases are associated with an increased risk of cardiovascular disease. We aimed to determine whether or not this is true, and to what extent, for a broad range of autoimmune conditions. METHODS: In this population-based study, we used linked primary and secondary care records from the Clinical Practice Research Datalink (CPRD), GOLD and Aurum datasets, to assemble a cohort of individuals across the UK who were newly diagnosed with any of 19 autoimmune diseases between Jan 1, 2000, and Dec 31, 2017, younger than 80 years at diagnosis, and free of cardiovascular diseases up to 12 months after diagnosis. We also assembled a matched cohort with up to five individuals matched on age, sex, socioeconomic status, region, and calendar year, who were free of autoimmune disease and free of cardiovascular diseases up to 12 months after study entry. Both cohorts were followed up until June 30, 2019. We investigated the incidence of 12 cardiovascular outcomes and used Cox proportional hazards models to examine differences in patients with and without autoimmune diseases. FINDINGS: Of 22 009 375 individuals identified from the CPRD databases, we identified 446 449 eligible individuals with autoimmune diseases and 2 102 830 matched controls. In the autoimmune cohort, mean age at diagnosis was 46.2 years (SD 19.8), and 271 410 (60.8%) were women and 175 039 (39.2%) were men. 68 413 (15.3%) people with and 231 410 (11.0%) without autoimmune diseases developed incident cardiovascular disease during a median of 6.2 years (IQR 2.7-10.8) of follow-up. The incidence rate of cardiovascular disease was 23.3 events per 1000 patient-years among patients with autoimmune disease and 15.0 events per 1000 patient-years among those without an autoimmune disease (hazard ratio [HR] 1.56 [95% CI 1.52-1.59]). An increased risk of cardiovascular disease with autoimmune disease was seen for every individual cardiovascular disease and increased progressively with the number of autoimmune diseases present (one disease: HR 1.41 [95% CI 1.37-1.45]; two diseases: 2.63 [2.49-2.78]); three or more diseases: 3.79 [3.36-4.27]), and in younger age groups (age <45 years: 2.33 [2.16-2.51]; 55-64 years: 1.76 [1.67-1.85]; >/=75 years: 1.30 [1.24-1.36]). Among autoimmune diseases, systemic sclerosis (3.59 [2.81-4.59]), Addison's disease (2.83 [1.96-4.09]), systemic lupus erythematosus (2.82 [2.38-3.33]), and type 1 diabetes (2.36 [2.21-2.52]) had the highest overall cardiovascular risk. INTERPRETATION: These findings warrant targeted cardiovascular prevention measures, in particular in younger patients with autoimmune diseases, and further research into pathophysiological mechanisms underlying these complications. FUNDING: Horizon 2020 Marie Sklodowska-Curie Actions and European Society of Cardiology. |
|---|
| ジャーナル名 | Lancet (London, England) |
|---|
| Pubmed追加日 | 2022/8/31 |
|---|
| 投稿者 | Conrad, Nathalie; Verbeke, Geert; Molenberghs, Geert; Goetschalckx, Laura; Callender, Thomas; Cambridge, Geraldine; Mason, Justin C; Rahimi, Kazem; McMurray, John J V; Verbakel, Jan Y |
|---|
| 組織名 | EPI-Centre, Academic Centre for General Practice, Department of Public Health and;Primary Care, KU Leuven, Leuven, Belgium. Electronic address:;nathalie.conrad@kuleuven.be.;Interuniversity Institute for Biostatistics and statistical Bioinformatics;(I-BioStat), Hasselt University and KU Leuven, Leuven, Belgium.;Primary Care, KU Leuven, Leuven, Belgium.;Department of Respiratory Medicine, University College London, London, UK.;Division of Medicine, Department of Rheumatology, University College London,;London, UK.;Faculty of Medicine, National Heart and Lung Institute, Imperial College London,;London UK.;Deep Medicine, Nuffield Department of Women's and Reproductive Health, University;of Oxford, Oxford, UK.;Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow,;UK.;Primary Care, KU Leuven, Leuven, Belgium; Nuffield Department of Primary Care;Health Sciences, University of Oxford, Oxford, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/36041475/ |
|---|
